Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fahn

Showing results (11-20 of 407) with videos related to

Pageof 41
Sort By:
Clinical Neuropharmacology|June 1, 1983
Treatment of tardive dyskinesia: use of dopamine-depleting agentsS Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 1998
Videotapes of motor complications of encephalitis lethargicaS Fahn
Advances in Neurology|January 1, 1979
Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogenS Fahn
Diseases of the Nervous System|October 1, 1972
Treatment of choreic movements with perphenazineS Fahn
Journal of Neurology|November 10, 1998
Medical treatment of Parkinson's diseaseS Fahn
The New England Journal of Medicine|November 7, 1985
Lack of benefit from cervical cord stimulation for dystoniaS Fahn
Seminars in Neurology|June 1, 1987
Drug treatment of hyperkinetic movement disordersS Fahn
Journal of Neural Transmission. Supplementum|April 24, 2007
Levodopa in the treatment of Parkinson's diseaseS Fahn
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
Clinical variants of idiopathic torsion dystoniaS Fahn
Annals of the New York Academy of Sciences|January 1, 1989
The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illnessS Fahn
Pageof 41

Showing results (11-20 of 407) with videos related to

Sort By:
Pageof 41
Clinical Neuropharmacology|June 1, 1983
Treatment of tardive dyskinesia: use of dopamine-depleting agentsS Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 1998
Videotapes of motor complications of encephalitis lethargicaS Fahn
Advances in Neurology|January 1, 1979
Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogenS Fahn
Diseases of the Nervous System|October 1, 1972
Treatment of choreic movements with perphenazineS Fahn
Journal of Neurology|November 10, 1998
Medical treatment of Parkinson's diseaseS Fahn
The New England Journal of Medicine|November 7, 1985
Lack of benefit from cervical cord stimulation for dystoniaS Fahn
Seminars in Neurology|June 1, 1987
Drug treatment of hyperkinetic movement disordersS Fahn
Journal of Neural Transmission. Supplementum|April 24, 2007
Levodopa in the treatment of Parkinson's diseaseS Fahn
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
Clinical variants of idiopathic torsion dystoniaS Fahn
Annals of the New York Academy of Sciences|January 1, 1989
The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illnessS Fahn
Pageof 41